|
|
| Name
: |
Louis G. Lange |
| Title
: |
Chairman of the Board, Chief Executive Officer |
| Since: |
08/1992 |
|
|
|
|
| Name
: |
Daniel K. Spiegelman |
| Title
: |
Chief Financial Officer, Senior Vice President |
| Since: |
01/1998 |
|
|
|
|
| Name
: |
Tricia B. Suvari |
| Title
: |
Senior Vice President, General Counsel, Secretary |
| Since: |
05/2000 |
|
|
|
|
| Name
: |
Brent K. Blackburn |
| Title
: |
Senior Vice President - Drug Discovery and Development |
| Since: |
10/1997 |
|
|
|
|
| Name
: |
Lewis J. Stuart |
| Title
: |
Senior Vice President - Commercial Operations |
| Since: |
07/16/2007 |
|
|
|
|
| Name
: |
Thomas L. Gutshall |
| Title
: |
Director |
| Since: |
12/1994 |
|
|
|
|
| Name
: |
Carol D. Karp |
| Title
: |
Senior Vice President, Regulatory Affairs, Quality, and Drug Safety |
| Since: |
|
|
|
|
|
| Name
: |
Diane L. Liguori |
| Title
: |
Senior Vice President, Human Resources, General Manager EU |
| Since: |
|
|
|
|
|
| Name
: |
John Mohr |
| Title
: |
Senior Vice President, Business Development |
| Since: |
|
|
|